The US is the only country in the world that doesn't negotiate drug prices. In this episode, Aaron Kesselheim delves into the complexities of America's pharmaceutical landscape, where prescription drug spending is causing challenges for millions who can't afford their medications. Shortages in critical drugs like ADHD medications and saline solutions, exacerbated by a supply chain heavily reliant on imports, leave the U.S. vulnerable during crises like the COVID-19 pandemic, Aaron explains, emphasizing the role of for-profit companies in exacerbating shortages and advocating for the Inflation Reduction Act (IRA) to allow Medicare to negotiate drug prices. Tune in and learn how you can advocate for better access to affordable medications and a more resilient healthcare system! Learn more about your ad choices. Visit megaphone.fm/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related